| Literature DB >> 26938215 |
Brett C Haberstick1, Jason D Boardman2, Brandon Wagner3, Andrew Smolen1, John K Hewitt1, Ley A Killeya-Jones4, Joyce Tabor4, Carolyn T Halpern4,5, Beverly H Brummett6, Redford B Williams6, Ilene C Siegler6, Christian J Hopfer7, Kathleen Mullan Harris3,4.
Abstract
BACKGROUND: The low transcriptionally efficient short-allele of the 5HTTLPR serotonin transporter polymorphism has been implicated to moderate the relationship between the experience of stressful life events (SLEs) and depression. Despite numerous attempts at replicating this observation, results remain inconclusive.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26938215 PMCID: PMC4777542 DOI: 10.1371/journal.pone.0148373
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Prevalence Rates for Depression as a function of 5-HTTLPR’ genotype status, two stressful environmental experiences and suicide ideation among young adult males and females.
Figs A and B (Top Row) graphically illustrate the prevalence of depression as a function of stressful life events; Figs C and D (Middle Row) illustrate the prevalence depression as a function of suicide ideation; and Figs E and F (Bottom Row) illustrate the prevalence of depression as a function of childhood maltreatment experiences.
Unstandardized Logistic Regression Estimates and Standard Errors Predicting Depression and Suicide Ideation.
| Depression Analysis for Full Sample | Maltreatment Analysis for Full Sample | Suicide Ideation Analysis for Full Sample | ||||||||||
| S.E. | S.E. | S.E. | ||||||||||
| Intercept | -3.39 | 0.19 | -2.40 | 0.14 | -3.92 | 0.36 | ||||||
| Sex (Female) | 0.55 | 0.10 | 0.70 | 0.11 | -0.27 | 0.16 | ||||||
| 5HTTLPR’ | 0.40 | 0.15 | 0.08 | 0.07 | 0.32 | 0.23 | ||||||
| SLE | 0.67 | 0.08 | 0.59 | 0.12 | ||||||||
| 5HTTLPR’xSLE | -0.16 | 0.07 | -0.07 | 0.09 | ||||||||
| Maltreatment | 0.45 | 0.14 | ||||||||||
| 5HTTLPR’x Maltreatment | -0.01 | 0.11 | ||||||||||
| Depression Analysis | Maltreatment Analysis | Suicide Ideation Analysis | ||||||||||
| Males | Females | Males | Females | Males | Females | |||||||
| S.E. | S.E. | S.E. | S.E. | S.E. | S.E. | |||||||
| Intercept | -4.06 | 0.35 | -2.47 | 0.24 | -2.47 | 0.20 | -1.65 | 0.11 | -3.59 | 0.33 | -4.52 | 0.50 |
| 5HTTLPR’ | 0.82 | 0.27 | 0.16 | 0.18 | 0.20 | 0.15 | 0.01 | 0.09 | 0.50 | 0.24 | 0.05 | 0.35 |
| SLE | 0.96 | 0.15 | 0.52 | 0.08 | 0.36 | 0.13 | 0.36 | 0.17 | ||||
| 5HTTLPR’xSLE | -0.33 | 0.12 | -0.07 | 0.08 | 0.13 | 0.11 | 0.13 | 0.12 | ||||
| Maltreatment | 0.43 | 0.24 | 0.48 | 0.15 | ||||||||
| 5HTTLPR’x Maltreatment | -0.10 | 0.22 | 0.03 | 0.13 | ||||||||
Note: 5HTTLPR’ genotype = 5HTTLPR + rs25531 snp; S.E., Standard Error. Uncorrected p-values are reported for post-hoc tests and did not remain significant following multiple test correction. Full regression results and 95% confidence intervals are provided for each analysis in S6 Table.
† Significant at P < 0.001.
‡ Significant at P < 0.01.
§ Significant at P < 0.05.